← FDA Drug Approvals (Drugs@FDA)

JUVISYNC

NDA · New Drug Application · Sponsor: MERCK SHARP DOHME · Approved 2011-10-07

Drug application

FDA Application #

NDA202343

Application type

New Drug Application

Brand name

JUVISYNC

Generic name

Simvastatin

Active ingredients

SIMVASTATIN; SITAGLIPTIN PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

MERCK SHARP DOHME

First approval

2011-10-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown